Individuals whose serum HIF-1α concentration surpassed 1411.00 pg/mL demonstrated statistically elevated probability of developing glioma than did those with lower ones (OR: 31.81, p < 0.01). The gene discussed is HIF1A; the disease is central nervous system cancer.